Skip to main content

Table 5 Serum testing results in immunoprophylaxis failure infants and their mothers

From: Serological positive markers of hepatitis B virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates

Group

No.

Mother

Infant

At birth

8–12 months

HBsAg

HBeAg

HBV-DNA

HBsAg

HBeAg

HBV-DNA

HBsAg

HBeAg

HBV-DNA

1

a

2685

1024

8.2

8537

897.9

6.2

968.2

1626

8.7

b

364.5

729.8

8.1

560.3

44.74

6.5

360.5

1516

7.4

c*

3319

447.9

8.2

6205

6.76

6.5

1647

1110

7.9

d*

1719

1762

7.6

1244

1771

8.5

901.1

1898

8.6

2

a

286.5

1367

6.5

122.3

22.08

3.8

256

900

7.4

b

98.13

305.6

7.6

6.74

138.2

3.9

391.1

878.1

8.0

c

1318.4

221.3

7.2

3.92

25.24

3.3

581.6

1220

7.1

d

47.8

27.6

6.5

5.13

9.02

4.3

2380

885.2

7.7

e*

1284

1226

7.6

3.71

11.51

3.8

980.3

1279

8.0

f*

3350

5020

7.7

55.72

+

3.2

2466

1256

7.5

3

a

379.6

961.4

6.9

2.97

12.25

378.8

565.1

7.6

b

971.6

9.707

7.4

4616

106.4

220

244.1

6.2

c

478.7

829.2

6.6

26.06

10.02

349.6

18.3

8.3

d

1419

813.9

6.8

1.39

108.2

3732

907.3

6.5

e

3255

785.1

6.6

0.48

11.44

4681

960.4

6.8

f*

1975

1316

7.3

17.66

+

5967

1449

5.7

g*

2407

1299

7.9

1.0

14.09

25.03

897.1

4.6

  1. The number labeled “*” represents UC and without “*” represents FV, HBsAg (COI), HBeAg (COI), HBV-DNA (log 10copies/mL); —: HBV-DNA < 500 copies/mL;+: This index was positive for qualitative analysis according to previous assay sheet and not tested by quantitative analysis because of insufficient sample